Table 3.
Synthetic and natural compounds regulating ferroptosis in cancer therapy.
Name | Molecular structure | Targets | Models | Tumor | Reference | Phase of clinical development |
---|---|---|---|---|---|---|
Sorafenib | ![]() |
GPX4 and SLC7A11 | Huh7, PLC/PRF5, PANC-1, BxPC-3, HCT116, and HT-29 cell lines | Hepatocellular carcinoma; pancreatic adenocarcinoma; colon carcinoma | [124, 130, 131] | Approved |
Cisplatin | ![]() |
GPX4 | Nude mice; A549, NCI‐H460, and H1299 cell lines | Lung cancer | [132] | Approved |
Erastin | ![]() |
ROS and iron | Xenograft models; DU145, PC3, 22Rv1, LNCaP, and NCI-H660 cell lines | Prostate cancer | [133] | Preclinical |
RSL3 | ![]() |
ROS and iron | Xenograft models; DU145, PC3, 22Rv1, LNCaP, and NCI-H660 cell lines | Prostate cancer | [133] | Preclinical |
JQ1 | ![]() |
GPX4 and system XC— | Nude mice; MDA-MB-231, Hs578T, and A549 cell lines | Breast cancer, lung squamous cell carcinoma | [136] | Preclinical |
PdPT | ![]() |
GPX4 | Nude mice; A549 and NCI-H1299 cell lines | Nonsmall cell lung cancer | [137] | Preclinical |
Lidocaine | ![]() |
SLC7A11 | Patient tumor tissues; nude mice; SKOV-3 and T47D cell lines | Ovarian and breast cancer | [138] | Preclinical |
Ketamine | ![]() |
GPX4 | Patient tumor tissues; BALB/c nude mice; HepG2 and Huh7 cell lines | Liver cancer | [67] | Approved |
MMRi62 | ![]() |
P53 | Patient tumor tissues, Panc1, BxPc3, panc10.05, AsPc1, Capan2, and SW1990 cell lines | Pancreatic cancer | [141] | Preclinical |
Bupivacaine | ![]() |
GPX4 and SLC7A11 | Nude mice; T24 and 5637 cell lines | Bladder cancer | [139] | Approved |
6-Gingerol (natural) | ![]() |
USP14 and GPX4 | Nude mice; A549 cell line | Lung cancer | [94] | Preclinical |
DMOCPTL (natural) | ![]() |
GPX4 | Bar b/c mice; MDAMB-231, SUM159, BT574, and 4T1 (mouse) cell lines | Triple-negative breast cancer | [146] | Preclinical |
Bufotalin (natural) | ![]() |
GPX4 | BALB/c nude mice; A549 cell line | Nonsmall cell lung cancer | [147] | Preclinical |
Alloimpertorin (natural) | ![]() |
GPX4 and SLC7A11 | MCF-10A, MDA-MB-231, and MCF-7 cell lines | Breast cancer | [149] | Preclinical |
GPX4 glutathione peroxidase 4, ROS reactive oxygen species, SLC7A11 solute carrier family 7 member 11, system XC—, cystine-glutamate antiporter, USP14 ubiquitin-specific protease 14.